Skip to content

AngioDynamics, Inc.

ANGO

CIK 0001275187

← back to feed
Revenue (TTM)
$305.57M
−3.8% YoY Q3 Mar 2026
Net Income (TTM)
−$29.74M
+81.6% YoY Q3 Mar 2026
EPS Diluted (TTM)
−$0.71
+81.9% YoY Q3 Mar 2026
Gross Margin
54.6%
Q3 Mar 2026
Operating Margin
-13.0%
Q3 Mar 2026
Net Margin
-9.7%
Q3 Mar 2026
Free Cash Flow (TTM)
−$88.23M
Q3 Mar 2026
Cash
$37.81M
Q3 Mar 2026
Total Debt
$124.41M
Q3 Mar 2026
Shares Outstanding
41.32M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings